Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis-Reference-Cited by-同舟云学术

Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis

Published:2015-08-18 Issue:8 Volume:10 Page:e0135378
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Marino Mariapaola,Scuderi Flavia,Samengo Daniela,Saltelli Giorgia,Maiuri Maria Teresa,Shen Chengyong,Mei Lin,Sabatelli Mario,Pani Giovambattista,Antonini Giovanni,Evoli Amelia,Bartoccioni Emanuela

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference35 articles.

1. An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis;J Lindstrom;Clin Immunol Immunopathol,1977

2. Signaling and aging at the neuromuscular synapse: lessons learnt from neuromuscular diseases;AR Punga;Curr Opin Pharmacol,2012

3. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis;MI Leite;Brain,2008

4. Diagnostic and clinical classification of autoimmune myasthenia gravis;S Berrih-Aknin;J Autoimmun,2014

5. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies;W Hoch;Nat Med,2001

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics of anti‐AChR‐MuSK‐LRP4 antibody‐negative myasthenia gravis in China;Muscle & Nerve;2023-04-03

2. Development and Application of a Cell-Based Assay for LRP4 Antibody Associated With Myasthenia Gravis;Journal of Clinical Neurology;2023

3. LRP4 antibody testing in myasthenia gravis;Journal of Neuroimmunology;2022-10

4. Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis;Journal of Neurology, Neurosurgery & Psychiatry;2022-07-14

5. Myasthenia Gravis: Novel Findings and Perspectives on Traditional to Regenerative Therapeutic Interventions;Aging and disease;2022